Jenscare Scientific Co., Ltd. (9877) Receives New Zealand Approval for Ken-Valve and LuX-Valve Plus

Bulletin Express

Feb 26

Jenscare Scientific Co., Ltd. (9877) has announced the receipt of registration approval from the New Zealand Medicines and Medical Devices Safety Authority for its Ken-Valve transcatheter aortic valve replacement system and LuX-Valve Plus transcatheter tricuspid valve replacement system.

The company is promoting the commercialization of these two products in New Zealand. According to the announcement, design advantages, ongoing registration clinical trials, and active treatment promotion initiatives have contributed to the widespread market recognition of Ken-Valve and LuX-Valve Plus.

Following the approval, the company intends to accelerate global commercialization of its product portfolio. However, there is no assurance of ultimately marketing them successfully, and shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1150452070"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150452070\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150452070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150452070","market":"us","top_or_hot":-1,"title":"Jenscare Scientific Co., Ltd. (9877) Receives New Zealand Approval for Ken-Valve and LuX-Valve Plus","media":"Bulletin Express","content":"<p>Jenscare Scientific Co., Ltd. (9877) has announced the receipt of registration approval from the New Zealand Medicines and Medical Devices Safety Authority for its Ken-Valve transcatheter aortic valve replacement system and LuX-Valve Plus transcatheter tricuspid valve replacement system.</p>\n<p>The company is promoting the commercialization of these two products in New Zealand. According to the announcement, design advantages, ongoing registration clinical trials, and active treatment promotion initiatives have contributed to the widespread market recognition of Ken-Valve and LuX-Valve Plus.</p>\n<p>Following the approval, the company intends to accelerate global commercialization of its product portfolio. However, there is no assurance of ultimately marketing them successfully, and shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jenscare Scientific Co., Ltd. (9877) Receives New Zealand Approval for Ken-Valve and LuX-Valve Plus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJenscare Scientific Co., Ltd. (9877) Receives New Zealand Approval for Ken-Valve and LuX-Valve Plus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-26 08:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jenscare Scientific Co., Ltd. (9877) has announced the receipt of registration approval from the New Zealand Medicines and Medical Devices Safety Authority for its Ken-Valve transcatheter aortic valve replacement system and LuX-Valve Plus transcatheter tricuspid valve replacement system.</p>\n<p>The company is promoting the commercialization of these two products in New Zealand. According to the announcement, design advantages, ongoing registration clinical trials, and active treatment promotion initiatives have contributed to the widespread market recognition of Ken-Valve and LuX-Valve Plus.</p>\n<p>Following the approval, the company intends to accelerate global commercialization of its product portfolio. However, there is no assurance of ultimately marketing them successfully, and shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09877","symbol_name":"健世科技-B","start_time":0,"source_url":"","article_id":"1150452070","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150452070","pubTimestamp":1772065259,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jenscare Scientific Co., Ltd. (9877) has announced the receipt of registration approval from the New Zealand Medicines and Medical Devices Safety Authority for its Ken-Valve transcatheter aortic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09877":"健世科技-B"},"translate_title":"Jenscare Scientific Co., Ltd.(9877)Ken-Valve和LuX-Valve Plus获得新西兰批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09877":1},"content_text":"Jenscare Scientific Co., Ltd. (9877) has announced the receipt of registration approval from the New Zealand Medicines and Medical Devices Safety Authority for its Ken-Valve transcatheter aortic valve replacement system and LuX-Valve Plus transcatheter tricuspid valve replacement system.\nThe company is promoting the commercialization of these two products in New Zealand. According to the announcement, design advantages, ongoing registration clinical trials, and active treatment promotion initiatives have contributed to the widespread market recognition of Ken-Valve and LuX-Valve Plus.\nFollowing the approval, the company intends to accelerate global commercialization of its product portfolio. However, there is no assurance of ultimately marketing them successfully, and shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}